LONDON, February 28 /PRNewswire/ -- Responding to guidance issued today by the Medicines and Healthcare products Regulatory Agency (MHRA), advising that cough and cold treatments should not be used for children under 6 years of age, the Royal Pharmaceutical Society of Great Britain (RPSGB) has issued the following advice to parents.
RPSGB's Director of Policy, David Pruce, says:
In view of the MHRA's new guidance, the RPSGB considers it good practice to restrict the use of some over-the-counter (OTC) products for the treatment of cough and cold symptoms in children under 6 years of age.
For children under 6 who have uncomplicated coughs and colds, the following medicines are suitable for use: